Navigation Links
Meningococcal-B Vaccine Greatly Reduces The Risk of The Disease

A new study has shown the children and teenagers who had been immunised against epidemic meningococcal B disease are five times less likely to be infected// than those who haven't been vaccinated.

Reports have shown that the biggest mass immunisation campaign that had taken place among the young New Zealanders has resulted in a five-fold reduction in the risk of acquiring Meningococcal B disease. The officials from the Ministry of health have stated that according to the initial results of the study conducted by the Victoria University of Wellington has showed that the children who were not immunised were almost five times more likely to suffer the disease. Stating that this disease has affected nearly 6,000 people since the epidemic began in 1981, they said that this disease has killed 239 people in a 25-year epidemic that has hit the country.

It has been reported that 1-in-5 of the survivors have been left with some degree of disability, that includes hearing loss, brain damage, amputation or scarring. Dr Jane O'Hallahan, the director of the immunisation programme has said that if the current trends continue, then substantial progress will been made towards ending the epidemic by the end of the year, which means it could be ended technically several years before its natural end.

Meningococcal disease is a bacterial infection, which causes severe illnesses including meningitis that is an infection of membranes covering the brain, and septicaemia a serious blood infection. Officials at the ministry have explained hat though anyone is vulnerable to the disease, the biggest risk group would be teenagers and children under 20 yrs of age, and more than half of those in that group are below 5 yrs.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
(Date:7/8/2008)...Pa., July 8 /PRNewswire/ -- The following statemen...rroway Topaz & Kessler, LLP:, Notice is hereby gi...nited States District Court for the Middle Distric...rities of Healthways Inc. (Nasdaq: HWAY ),("Healt...ough February 26,2008, inclusive (the "Class Peri...
(Date:7/8/2008)...ns Cite Patient Concerns about Delays in Oxygen Or..., July 8 /PRNewswire-USNewswire/ -- The new Medica... equipment has created,concern and chaos for benef..., and home medical equipment providers across the ...n areas on July 1., The bidding program has trigg...
(Date:7/8/2008)...N, July 8, 2008) The American Society of Hematolo...ents of its Alternative Training Pathway Grant. Th...encourage the development and implementation of no...mas Abshire, MD, of Emory University, Donald Mahon...id Sternberg, MD, PhD, of Mount Sinai School of Me...
(Date:7/8/2008)...lure Study Validates Use of Pharos Innovation,s Pr...to Reduce Healthcare Utilization and ...uly 8 /PRNewswire/ -- Pharos Innovations, a pionee...clinical and financial,performance improvement thr...ounced today the results from the Iowa Medicaid Co...
Breaking Medicine News(10 mins):Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...A new study published in the journal, Human Mutati...enes that are responsible for noise induced hearin...twerp//, Belgium found that three genes involved i...ted. The study led by Professor Guy Van Camp ident...
...One-year-old James Hynes, from Dundrod, UK has und...nsplant operation in Germany//.Doctors told his pa...t be saved. After an extensive public campaign, th...ents found a German doctor through a website and h...
...Health Minister Mary Harney has plans to introduce...blished within the next week or so//. She is seeki...f bill for new legislation next week or the follow...Practitioners Bill can be published later this yea...
...The White House has declared on Thursday that it w...cipients from the new law which requires them to g...rts, birth certificates or other documents. This ...e-empt a ruling by a federal judge who is schedule...
Other Medicine News:Health News:Bush Administration to Exempt Medicaid Recipients on Proof of Citizenship 2
(Date:7/7/2008)...ment Presence Includes ANA598 and ANA773 Acting vi...ry Mechanisms Conference Call Tod...FirstCall/ -- Anadys Pharmaceuticals,Inc. (Nasdaq...ical,investigation of the Toll-Like Receptor-7 (TL...is C. Based on preclinical pharmacology testing,an...
(Date:7/7/2008)...RNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bul...ded biopharmaceutical,company specializing in the ...oday provided an operational update on the company...human clinical trial testing and,plans to proceed ...e. Five,successful human trials evaluating GeoVax ...
(Date:7/7/2008)...gests Kiwifruit is Top Performer in the Body, SEA...eated equal when,it comes to their antioxidant pow... bioavailability compared to other antioxidant-ric... published in the Journal of the,American College ...phytochemicals called flavonoids that,may have the...
(Date:7/3/2008)...ly 3 /PRNewswire-USNewswire/ -- All newborn infant...hat is present at birth,according to a new recomm...rce. The recommendation and the accompanying summa...trics., Children whose hearing is impaired at bir...problems with verbal and nonverbal communication a...
Breaking Medicine Technology:Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Kiwifruit: Antioxidant Power in Quantity and Quality 2Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday November 14 2007 5924 1Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday November 14 2007 5924 25 000 Patients Treated With OrbusNeichs Genous 28TM 29 Bio engineered R Stent 28TM 29 Now Enrolled in Real Life Use Global Registry 5922 15 000 Patients Treated With OrbusNeichs Genous 28TM 29 Bio engineered R Stent 28TM 29 Now Enrolled in Real Life Use Global Registry 5922 2California Restaurant Association Chooses EMPLOYERS 28R 29 as its New Provider of Choice for Members Workers Compensation Insurance Needs 5920 1California Restaurant Association Chooses EMPLOYERS 28R 29 as its New Provider of Choice for Members Workers Compensation Insurance Needs 5920 2National physician organization supports Capps Rogers Bill at todays congressional briefing 5918 1National physician organization supports Capps Rogers Bill at todays congressional briefing 5918 2
...May 14, 2007 - Acceleron Pharma,Inc., a biopharma...reatment of musculoskeletal, metabolic and cancer-...clinical study with,ACE-031 that demonstrated the ...d strength in normal mice and in murine models of,...lators of muscle,to increase muscle mass and stren...
...rket dynamics offers insights into,what will be ne...ients, NEW YORK, May 14, 2007 /PRNewswire-USNewsir...(TB Alliance), a not-for-profit,product developme...lopment of new TB drugs, today released results fr...f the global TB drug market,that offers a detailed...
Other Medicine Technology:Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 2Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 2New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 3New Study Reveals Limitations of a Complex and Challenging Global,Tuberculosis Drug Marketplace 4
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: